{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:28:05Z","timestamp":1759332485449},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zydus Research Centre","award":["ZRC-410"],"award-info":[{"award-number":["ZRC-410"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.intimp.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:01:15Z","timestamp":1372464075000},"page":"229-236","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Selective inhibition of tumor necrosis factor-\u03b1 converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis"],"prefix":"10.1016","volume":"17","author":[{"given":"Manoranjan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jogeswar","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshaya","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiren M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dheerendra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekhar","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gourang B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukul R.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.06.014_bb0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2013.06.014_bb0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1568-9972(03)00017-X","article-title":"Autoimmune hepatitis","volume":"2","author":"Vergani","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.intimp.2013.06.014_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12072-010-9196-0","article-title":"Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis)","volume":"4","author":"Zhang","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.intimp.2013.06.014_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jlb.57.5.774","article-title":"Matrix metalloproteinases and processing of pro-TNF-alpha","volume":"57","author":"Gearing","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0035","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.158.1.438","article-title":"Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice","volume":"158","author":"Akassoglou","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0045","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","article-title":"Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha","volume":"168","author":"Olleros","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0050","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3899\/jrheum.081041","article-title":"Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections","volume":"36","author":"Aggarwal","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4049\/jimmunol.158.1.414","article-title":"Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor","volume":"158","author":"Solorzano","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0168-8278(98)80179-7","article-title":"Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix","volume":"29","author":"Shirin","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0065","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6","volume":"179","author":"Mizuhara","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.06.014_bb0070","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.4049\/jimmunol.160.8.4082","article-title":"Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis","volume":"160","author":"Ksontini","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0075","doi-asserted-by":"crossref","first-page":"e11256","DOI":"10.1371\/journal.pone.0011256","article-title":"Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice","volume":"5","author":"de Meijer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.06.014_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1872-034X.2009.00541.x","article-title":"Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse","volume":"39","author":"Kahraman","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.intimp.2013.06.014_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2012.12.002","article-title":"Blockade of tumor necrosis factor-alpha converting enzyme (TACE) enhances IL-1beta and IFN-gamma via caspase-1 activation: A probable cause for loss of efficacy of TACE inhibitors in humans?","volume":"701","author":"Sharma","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.06.014_bb0095","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2013.06.014_bb0100","first-page":"1608","article-title":"Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis","volume":"23","author":"Mizuhara","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2013.06.014_bb0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(94)80256-4","article-title":"Immunotoxicology of host-response-mediated experimental liver injury","volume":"21","author":"Tiegs","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2013.06.014_bb0115","first-page":"225","article-title":"Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist","volume":"6","author":"Butler","year":"1995","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.intimp.2013.06.014_bb0120","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1073\/pnas.0501758102","article-title":"The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.intimp.2013.06.014_bb0125","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jhep.2010.05.029","article-title":"Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis","volume":"53","author":"Olleros","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0130","first-page":"93","article-title":"Tumor necrosis factors: developments during the last decade","volume":"7","author":"Aggarwal","year":"1996","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.intimp.2013.06.014_bb0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrm2393","article-title":"Expansion and evolution of cell death programmes","volume":"9","author":"Degterev","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/cdd.2012.90","article-title":"TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation","volume":"19","author":"Jouan-Lanhouet","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.intimp.2013.06.014_bb0145","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1091\/mbc.01-05-0272","article-title":"Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling","volume":"13","author":"Los","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.intimp.2013.06.014_bb0150","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0960-9822(00)80113-X","article-title":"The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis","volume":"9","author":"Powell","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0155","first-page":"577","article-title":"Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity","volume":"61","author":"Mitsiades","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2013.06.014_bb0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.06.014_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2013.06.014_bb0170","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.4049\/jimmunol.1102199","article-title":"Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis","volume":"188","author":"Murthy","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0175","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/intimm\/11.9.1491","article-title":"Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A","volume":"11","author":"Kimura","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2013.06.014_bb0180","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2013.06.014_bb0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2013.06.014_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10753-008-9067-1","article-title":"Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis","volume":"31","author":"Bahcecioglu","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2013.06.014_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10753-007-9053-z","article-title":"The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet","volume":"31","author":"Koca","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2013.06.014_bb0200","first-page":"598","article-title":"BMS-561392. Bristol-Myers Squibb","volume":"4","author":"Grootveld","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.intimp.2013.06.014_bb0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1039\/c0md00261e","article-title":"Design, synthesis and biological evaluation of \u03b3-lactam hydroxamate based TACE inhibitors","volume":"2","author":"Argade","year":"2011","journal-title":"Med Chem Commun"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:02:34Z","timestamp":1688324554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913002555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1567576913002555"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.06.014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of tumor necrosis factor-\u03b1 converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}